US$ 20.07
semaglutide korea Wegovy 0.5mg Korea's anti-obesity drug race in
Description
For those with Type 2 diabetes, semaglutide can help lower blood sugar levels by making the body produce more insulin when blood sugar is high

No clutter

Studies reported loss of up to 15-22% of body weight without restrictive dieting or vigorous exercise

Personalized Care: Tailored to your unique needs

It's important to note that while Wegovy is licensed in the UK, NHS availability is more restricted under NICE Technology Appraisal 875, which limits access to specialist weight management services for patients meeting specific BMI thresholds, with treatment typically limited to a maximum of 2 years

These factors combine to make Asia-Pacific the fastest-growing region for GLP-1 receptor agonist adoption and market expansion globally
